Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: J Rheumatol. 2009 Nov 2;36(12):2682–2690. doi: 10.3899/jrheum.090338

Figure 3.

Figure 3

Correlations among antibodies to CCP, CAP, and ribosomal P peptide by ELISA. A. RA sera (n = 47) were tested for anti-CCP versus anti-CAP. B. Anti-CCP versus anti-CAP in SLE sera (329 Americans, 6 Japanese). C. Anti-CCP versus anti-CAP in SLE cases with deforming/destructive arthropathy (subset I: 20 Americans, 6 Japanese). D. Anti-CCP versus anti-ribosomal P peptide antibodies in SLE sera (n = 329 Americans).